Antihyperlipidemic Drugs Market Size 2022 Share, Industry Growth, Report Analysis and Trends 2027
According to the latest report by IMARC Group, titled " Global Antihyperlipidemic Drugs Market Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027 ", the global antihyperlipidemic drugs market size reached a value of US$ 11.31 Billion in 2021 . Looking forward, IMARC Group expects the market to reach a value of US$ 15.81 Billion by 2027 , exhibiting a CAGR of 5.20% during 2022-2027. Antihyperlipidemic drugs are used to lower serum levels of cholesterol in the blood. They are prescribed along with different medications to control the lipid level in the blood that can also lead to obesity, hypertension, diabetes, and hyperlipidemia. These drugs also assist in increasing the high-density lipoprotein cholesterol in the body and preventing coronary heart conditions. Some of the commonly available antihyperlipidemic drugs include bile acid sequestrants, antihyperlipidemic agents, and cholesterol absorption inhibitors. We are regularly tracking the direct effe...